• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX 180NR DIALYZER FINISHED ASSMBLY; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OGDEN MANUFACTURING PLANT OPTIFLUX 180NR DIALYZER FINISHED ASSMBLY; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 0500318N
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code Hemorrhage/Blood Loss/Bleeding (1888)
Date of Event 10/20/2023
Type of Reportable Event Malfunction
Event or Problem Description
A user facility certified clinical hemodialysis technician (ccht) reported a dialyzer blood leak occurred during a patient's hemodialysis (hd) treatment.Treatment was discontinued and the patient's blood was not returned.Upon follow-up, the clinic manager (cm) stated immediately after initiation of hd treatment, blood was noticed leaking from a crack in the dialyzer head.Per cm the blood leak was external.The machine, a 2008t, was used and stated the machine did not alarm with a blood leak alert.Blood test strips were used and tested negative for the presence of blood.The patient was utilizing fresenius combi set bloodlines and the patient's blood was not returned.No damage was noted on the dialyzer prior to treatment.Immediately following the event, the patient was re-setup with new supplies on the same machine and completed treatment without issue.The estimated blood loss was 300ml.It was confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The dialyzer was no longer available to be returned for manufacturer evaluation.
 
Additional Manufacturer Narrative
Plant investigation: the plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Event or Problem Description
A user facility certified clinical hemodialysis technician (ccht) reported a dialyzer blood leak occurred during a patient's hemodialysis (hd) treatment.Treatment was discontinued and the patient's blood was not returned.Upon follow-up, the clinic manager (cm) stated immediately after initiation of hd treatment, blood was noticed leaking from a crack in the dialyzer head.Per cm the blood leak was external.The machine, a 2008t, was used and stated the machine did not alarm with a blood leak alert.Blood test strips were used and tested negative for the presence of blood.The patient was utilizing fresenius combi set bloodlines and the patient's blood was not returned.No damage was noted on the dialyzer prior to treatment.Immediately following the event, the patient was re-setup with new supplies on the same machine and completed treatment without issue.The estimated blood loss was 300ml.It was confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The dialyzer was no longer available to be returned for manufacturer evaluation.
 
Additional Manufacturer Narrative
Plant investigation: the reported complaint was not confirmed as the complaint device was not returned for manufacturer evaluation.A production records review was performed on the reported lot.During the lot history review it was noted that there were three other complaints reported against the lot.The complaints address three patient's having a reaction to treatment (from the same clinic), which are unrelated to the current event.An investigation of the device history records (dhr) was conducted by the manufacturer.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.A definitive conclusion regarding the complaint incident cannot be reached without physical examination of the actual device.Therefore, the complaint is not confirmed.The reported lot number passed pyrogen testing, was within sterilization dosage parameters and passed all release criteria.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLUX 180NR DIALYZER FINISHED ASSMBLY
Common Device Name
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer (Section G)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key17987123
Report Number0001713747-2023-00726
Device Sequence Number20882674
Product Code KDI
UDI-Device Identifier00840861100125
UDI-Public00840861100125
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
K002277
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 11/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/28/2026
Device Catalogue Number0500318N
Device Lot Number23BU04024
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/20/2023
Supplement Date Received by Manufacturer11/13/2023
Initial Report FDA Received Date10/23/2023
Supplement Report FDA Received Date11/13/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured02/27/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
FRESENIUS 2008T MACHINE.; FRESENIUS 2008T MACHINE.; FRESENIUS BLOODLINES.; FRESENIUS BLOODLINES.
Patient Age83 YR
Patient SexFemale
Patient Weight94 KG
-
-